Universal Influenza Vaccine Update

Published Online: Monday, January 28, 2013
Follow Pharmacy_Times:
In this video, recorded at ICAAC 2012, the American Society for Microbiology’s annual infectious diseases meeting, Jeff Fox, PhD, features editor of Microbe, talks with Donna Ambrosino and Zachary Shriver of Visterra Inc about efforts to develop a universal influenza vaccine that will be capable of protecting against any potential strain of the influenza virus. Currently, the influenza vaccine must be updated annually to protect against the strains of influenza expected to circulate in a given year, leaving people vulnerable to novel virus strains.

Related Articles
The FDA has approved the first needle-free device for injecting the Afluria influenza vaccine in adult patients aged 18 to 64 years.
Key points from the Infectious Diseases Society of America’s updated guidelines for vaccination of immunocompromised individuals.
In a large-scale trial, Sanofi’s Fluzone High-Dose vaccine demonstrated efficacy in preventing influenza specifically in adults aged 65 years or older.
Latest Issues
$auto_registration$